The Ministry of Economy has proposed to fine pharmaceutical companies for selling drug analogs before the patent for the original drug expires. The fine can range from 50% to 200% of the proceeds from the sale of such funds. The bill provides for the introduction of new sanctions as of September 1, 2027. Officials face fines of 10,000-50,000 rubles, and the accounts of the offending companies can be seized to ensure payments. The Ministry of Economy believes that current fines of up to 40 thousand rubles do not stop the violators, since the potential profit from the sale of drugs significantly exceeds the amount of the penalty.

The Ministry of Economy has proposed to fine pharmaceutical companies for selling drug analogs before the patent for the original drug expires. The fine can range from 50% to 200% of the proceeds from the sale of such funds. The bill provides for the introduction of new sanctions as of September 1, 2027. Officials face fines of 10,000-50,000 rubles, and the accounts of the offending companies can be seized to ensure payments. The Ministry of Economy believes that current fines of up to 40 thousand rubles do not stop the violators, since the potential profit from the sale of drugs significantly exceeds the amount of the penalty.